Biobanks Market Size & Share | Industry Forecast 2021, 2028
市场洞察
2021 年全球生物库市场价值 24.1831 亿美元,预计到 2028 年将达到 37.5864 亿美元, 2021-2028 年期间的复合年增长率为 6.5%。
疾病研究资金和基因组研究活动的增加、制药和生物制药研发费用的增加以及再生医学的日益普及是生物库市场增长的潜在因素 。相反,自动化的高成本阻碍了全球生物库市场的扩张。
生物库提供生物样本(如血液)以及医疗保健数据的收集。生物库可能很大,包括数千个样本,也可能很小,只包含几百个样本。不同的生物库收集不同的样本和信息以评估特定功能。主要市场参与者通过多种有机和无机增长战略优化了其增长。
从地区来看,北美占据全球生物库市场的最大份额,并可能在预测期内保持主导地位。预计亚太地区在预测期内的复合年增长率最高。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
全球生物库市场:
Global Biobanks Market: Strategic Insights
Global Biobanks Market
-
CAGR (2021 - 2028)
6.5%
-
Market Size 2021
US$ 2.42 Billion
-
Market Size 2028
US$ 3.76 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- THERMO FISHER SCIENTIFIC INC
- Tecan Trading AG
- QIAGEN
- Hamilton Company
- Avantor Inc
- MICRONICS JAPAN CO LTD
- BD
- Taylor Wharton
- Brooks Automation Inc
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
产品和服务(设备、耗材、服务和软件)
样本(血液制品、人体组织、细胞系等)
应用(再生医学、生命科学研究、临床研究)
Global Biobanks Market: Strategic Insights
-
CAGR (2021 - 2028)6.5% -
Market Size 2021
US$ 2.42 Billion -
Market Size 2028
US$ 3.76 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- THERMO FISHER SCIENTIFIC INC
- Tecan Trading AG
- QIAGEN
- Hamilton Company
- Avantor Inc
- MICRONICS JAPAN CO LTD
- BD
- Taylor Wharton
- Brooks Automation Inc
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2021 - 2028 年)6.5%- 2021 年市场规模
24.2 亿美元 - 2028 年市场规模
37.6 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 赛默飞世尔科技公司
- Tecan 贸易公司
- 凯杰公司
- 汉密尔顿公司
- Avantor 公司
- 密克罗尼克斯日本有限公司
- 屋宇署
- 泰勒-沃顿
- 布鲁克斯自动化有限公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 设备
- 耗材
- 服务
- 软件
- 血液制品
- 人体组织
- 细胞系
- 其他的
- 再生医学
- 生命科学研究
- 临床研究
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
COVID-19的影响
采样、分析和疫苗生产中的应用助力全球生物库市场增长
全球 COVID-19 疫情对全世界的医疗、经济和社会产生了深远影响。北美的医疗系统在评估 COVID-19 影响的人口统计学方面面临一个紧迫的问题。在疫情初期,加拿大的生物银行活动被视为非必要的医疗服务,但随着研究活动的出现,与疾病相关的研究得到了允许和发表。美国利用虚拟护理和远程监控策略来确保患者获得全面的临床支持。生物银行在疫情期间成为一项必要的服务,有助于加快关键研究工作的开展。全球生物银行不得不购买额外的个人防护装备 (PPE) 套件,以保护医务人员免受感染。此外,他们还在全球范围内沟通收集和储存样本所需的材料。
在欧洲,生物库被证明对减轻 COVID-19 的影响极为有帮助,因为它们为研究人员提供了评估病情、研制疫苗和疗法所需的样本。在疫情期间,生物库在研究、采样和疫苗接种方面发挥了至关重要的作用。如果没有从受感染患者身上采集样本,就不可能让整个科学界都能获得 SARS-CoV-2 病毒的基因组,也不可能在创纪录的时间内生产出疫苗。亚太生物库市场曾饱受道德困境和基础设施挑战的困扰,但未来可能会迅速增长。印度医学研究理事会 (ICMR) 批准了 16 个生物库,用于收集、储存和保存 COVID 感染患者的临床样本。
未来的趋势
虚拟生物库
虚拟存储库提供从传统生物库中存储的样本中提取和表征的数据。虚拟生物库的数据库提供样本和其他特征数据的高分辨率图像。这些生物库可以通过专门的软件或网络门户访问。它们允许访问记录的数据格式,而无需物理样本。虚拟生物库通常用于生物信息学,包含有价值的临床活检标本的 2D 和 3D 显微镜数据集。该系统已成为提高样本可见性和可访问性的实用选择。研究人员可以使用虚拟生物库来识别他们需要的产品和服务,以简化和管理生物库过程的关键阶段。虚拟系统集成可能会在未来推动全球生物库市场的发展。
驱动程序
疾病研究资金和基因组研究活动不断增加
在政府大量投资的帮助下,基因组测序正在迅速转变为临床实践和医疗保健系统。国家基因组医学计划正在推动医疗系统的变革。英国宣布了世界上最大的基因组项目,这是慈善机构和制药公司之间 2 亿公私合作的一部分。该项目将资助研究人员和行业将英国卫生服务的数据和现实证据结合起来。总部位于马萨诸塞州的 Boston 公司获得了 430 万美元的种子资金,与基因组测序公司 Veritas Genetics 合作。生物库一直是传染病和宿主基因组研究的重要资源。来自生物库的数据有助于了解由基因突变引起的多因素疾病的病因。
再生医学的采用日益增多
再生疗法有助于诱导细胞、组织和器官的再生,以恢复其功能。美国食品药品监督管理局 (FDA) 每年都会收到大量用于人体临床试验的再生医学申请。再生医学的快速发展为慢性病带来了有效的解决方案,有可能推动全球生物库市场的增长。细胞疗法是再生医学领域增长最快的领域之一。诺华 Kymriah 是首个治疗 B 细胞急性白血病的细胞疗法解决方案。生物库一直是再生医学的重要资产,因为它为研究、开发和治疗提供了材料。投资生物库可以带来可观的成本回收,以支持再生医学和组织工程计划。
限制
自动化成本高
昂贵的自动化一直是全球生物库市场增长的主要障碍。先进的特性和功能使得生物样本存储仪器价格昂贵。此外,由于生物库运营的成本不仅限于自动化,公司会评估影响其整体财务稳定性的各种因素。自动化的总支出包括购买设备、其他基础设施和根据需求进行流程改进的成本。自动化系统的成本在开始时可能是手动操作的五到十倍。对于完全维护的自动化,十年的运营成本预计在 57 万美元至 566 万美元之间。研究公司为自动化整合支付了更多费用。这种高度昂贵的自动化系统可能会抑制全球生物库市场的增长。
市场细分
按产品和服务
存储和处理需求刺激了细分市场的增长
全球生物库市场按产品和服务分为设备、耗材、服务和软件。设备部分在 2021 年占据了最大的市场份额,并将持续占据主导地位,直到 2028 年。设备在生物库产品的制造中起着至关重要的作用。它在存储的每个阶段都至关重要。因此,生物材料的存储、处理和研究管理需要不同类型的设备。该部分进一步分为存储、样品分析、样品处理和样品运输设备。
消耗品是第二大市场吸引力,预计在预测期内也将以最高的复合年增长率增长。培养皿、试管、移液器和烧杯等消耗品在样品采集、制备、分析、储存和运输的每个步骤中都会用到。此外,在质量控制过程中也需要它们来确保适当的测试。细分市场的增长主要归因于研究和学术机构以及生命科学公司对消耗品的使用。
按样本
采样和分析的要求增强了该领域的主导地位
根据样本,全球生物库市场细分为血液制品、人体组织、细胞系等。2021 年,血液制品占据了市场主导地位,收入份额最大,预计在 2021-2028 年期间将以最高复合年增长率飙升。血液是人类生物库中收集的最常见生物样本之一,因为它是 DNA 和 RNA 的来源。人类生物样本中的生物库需要白膜和全血样本。
细胞系部分紧随血液制品之后,占据第二大市场份额。患者来源的细胞系对于基础研究、高通量药物筛选和新药剂评估至关重要。生物库在干细胞研究中维护人类胚胎干细胞系方面发挥着至关重要的作用。许多细胞系本质上都是独一无二的,例如从唐氏综合症患者身上获得的诱导性多能干细胞。
区域洞察
从地理上看,全球生物库市场分为北美洲、欧洲、亚太地区 (APAC)、南美洲和中美洲 (SCAM) 以及中东和非洲 (MEA)。
2021 年,北美占据了最大的市场份额,预计到 2028 年仍将保持主导地位。高度结构化的医疗保健行业、突破性产品的早期接受、慢性病的流行、药物发现的突破、政府和非政府组织的投资增加以及关键参与者的存在是推动区域生物库市场发展的潜在参数。在美国,再生医学研究越来越集中和先进,使疾病逆转成为可能。据观察,干细胞有可能治疗以前被认为无法治愈的多种疾病。不断扩大的研究机构、学生和研究人员对各种基因研究的兴趣日益浓厚、跨国公司的投资以及政府举措是推动加拿大生物库市场增长的主要因素。
亚太生物库市场在预测期内可能以最高的复合年增长率扩张。生物库是该地区为未来研究和开发保存生物资源和数据的众多举措之一。作为政府协调战略计划的一部分,中国在生物库活动方面尤其活跃。该国还提前建立了亚洲生物库网络,以确保资源和专业知识共享。为了建立稳定的运营系统,亚太地区的生物库标准化了运营程序并实现资金来源多样化。印度政府资助转化研究机构来治疗各种疾病,使国家更具创新性和可持续性。
生物库市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 24.2亿美元 |
2028 年市场规模 | 37.6亿美元 |
全球复合年增长率(2021 - 2028) | 6.5% |
历史数据 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按产品和服务
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
主要市场参与者:
- 赛默飞世尔科技公司(美国)
- Tecan Trading AG(瑞士)
- QIAGEN(荷兰)
- 汉密尔顿公司(美国)
- Avantor, Inc(美国)
- Micronics Japan 有限公司 (日本)
- BD(美国)
- 泰勒-沃顿(美国)
- Brooks Automation, Inc(美国)
- Biovault 家族(英国)
- Promega 公司 (美国)
- SciSafe Inc.(美国)
主要进展:
2021 年 12 月:
赛默飞世尔科技公司以 174 亿美元收购了全球领先的临床研究服务提供商 PPD 公司。2021 年 8 月:
Tecan集团完成对美国Paramit Corporation及其附属公司的收购,总收购价为10亿美元。2022 年 1 月:
QIAGEN 宣布其超灵敏数字 PCR 平台 QI Acuity 不断增加的应用新增功能,该平台使用纳米板仅需两小时即可处理样品。2021 年 7 月:
BD 收购了 Tepha Inc.,后者是一家专有可吸收聚合物技术的领先开发商和制造商。
报告范围
全球生物库市场研究报告提供了有关市场规模、份额、趋势和预测的详细见解。它提供了有关驱动因素、限制因素、机会、细分市场和行业格局的清晰而精确的专业知识。讨论了 COVID-19 影响分析以及在全球和区域市场中观察到的机会。一份关键市场参与者名单及其近年来各自的发展情况被特别提及。
Global Biobanks Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 2.42 Billion |
Market Size by | US$ 3.76 Billion |
Global CAGR | 6.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品和服务(设备、耗材、服务和软件) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The blood products segment dominated the global biobanks market and accounted for the largest market share of 75.47% in 2021.
A biobank is a collection of biological samples (such as blood) as well as health data. Biobanks might be vast, including thousands of samples, or small, containing only a few hundred. Different sorts of samples and information are collected by different biobanks. The information and samples gathered are determined by the biobank's specific function. The term biobank covers collections of plants and animals, including human specimens.
Key factors that are driving the growth of this market are the growing funding and genomic research activities for studying diseases, increasing pharmaceutical and biopharmaceutical R&D expenditures, and rising adoption of regenerative medicines are expected to boost the market growth for the biobanks over the years.
The CAGR value of the biobanks market during the forecasted period of 2021-2028 is 6.5%.
The equipment segment held the largest share of the market in the global biobanks market and held the largest market share of 54.38% in 2021.
The regenerative medicine segment dominated the global biobanks market and accounted for the largest market share of 48.92% in 2021.
The biobanks market majorly consists of players such Thermo Fisher Scientific Inc., Tecan Trading AG, QIAGEN, Hamilton Company, Avantor, Inc., Micronics Japan Co.,Ltd., BD, Taylor-Wharton, Brooks Automation, Inc., Biovault Family, Promega Corporation, and SciSafe Inc. amongst others.
Hamilton Company. and Avantor, Inc. are the top two companies that hold huge market shares in the Biobanks market.
Global biobanks market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share for biobanks in 2021. The United States held the largest market in North America for biobanks, and the market is expected to grow due to the increasing adoption of technological advancements and rising innovations in regenerative medicine are projected to accelerate the growth of the biobanks market.
Biobanking became a necessary service as a result of this development, allowing for faster COVID-19 research and the continuation of critical research operations. During the epidemic, navigating the scarce and frequently competing healthcare supply chains was critical for continuous operational demands. Global biobanks have had to purchase extra personal protective equipment (PPE) to safeguard their personnel from COVID-19, and even employees have had to be regularly checked for suspected COVID-19 symptoms. Biobanks had to communicate and search globally for the materials they required to quickly collect and store specimens. Biobanks are critical in collecting and preserving bio samples such as plasma, serum, DNA and RNA, clinical data, and genomic data due to the large number of clinical trials related to COVID-19.
The List of Companies - Biobanks Market
- THERMO FISHER SCIENTIFIC INC.
- Tecan Trading AG
- QIAGEN
- Hamilton Company
- Avantor, Inc.
- MICRONICS JAPAN CO., LTD.
- BD
- Taylor-Wharton
- Brooks Automation, Inc
- Biovault Family
- Promega Corporation
- SciSafe Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.